Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancerRumeysa Ciftci a, Faruk Tas b, Elif Bilgin c, Serkan Keskin b, Ibrahim Yildiz b, Derya Duranyildiz c, Pınar Saip b, Hasan Karanlikd, Sezai Vatansever ba Bakirkoy Dr Sadi Konuk Education and Research Hospital, Medical Oncology Department, Istanbul, Turkey
b Istanbul University, Institute of Oncology, Medical Oncology Department Capa, Istanbul, Turkey
c Istanbul University, Institute of Oncology, Basic Oncology Department Capa, Istanbul, Turkey
d Istanbul University, Institute of Oncology, Surgical Oncology Unit, Capa, Istanbul, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.04.003 Sayfalar: 7 - 11 1417 Viewed.
JOURNAL of
EN